AACOMmunities

Federal Funding Opportunities and Resources

Below is a selected list of timely federal funding opportunities that are relevant to the osteopathic medical education community. AACOM updates this resource frequently.  Please bookmark the page for your reference. For a comprehensive listing of federal funding opportunities, please visit Grants.gov.   

Featured Opportunities

September 2 – September 13  

National Institutes of Health

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Application Due: May 7, 2021

The purpose of this grant is to support projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)

Application Due: January 8, 2020

The purpose of this grant is to support innovative clinical, preclinical and non-clinical research to determine the potential of MDSCs as a target for host-directed therapeutics for tuberculosis in the context of HIV co-infection, and to better understand the role of host-induced immunosuppression in the progression of Mycobacterium tuberculosis pathogenesis.

Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)

Letter of Intent Due: November 2, 2019

Application Due: December 2, 2019

The purpose of this grant is to support high risk/high reward research on the blood/vascular component and regulation of the neurovascular blood unit (aka. Blood-Brain Barrier; BBB) in normal and pathological states to stimulate the development of a new field of science and re-define the neurovascular unit to also include the blood/vascular component to identify targets for diagnostics and regulation of the Blood-Brain Interface.

The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)

Letter of Intent Due: October 15, 2019

Application Due: November 15, 2019

The purpose of this grant is to help researchers participate in the National Drug Abuse Treatment Clinical Trials Network (CTN). NIDA intends to continue to develop and test interventions to address a variety of substance use problems via collaborative partnerships among NIDA, clinical research investigators, and healthcare providers and institutions.

Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Scientific and Data Coordinating Center (U24 Clinical Trial Optional)

Letter of Intent Due: October 7, 2019

Application Due: November 7, 2019

The purpose of this grant is to establish the knowledge and evidence base necessary to permit future studies of prevention of LUTS in adolescent and adult women. In general, prevention research takes a multi-factorial approach to include: epidemiologic studies to identify and assess risk and protective factors; to screen and identify individuals and groups at risk; to develop and evaluate interventions designed to reduce risk; and translate and disseminate effective preventive interventions into practice.

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)

Letter of Intent Due: October 1, 2019

Application Due: November 1, 2019

The purpose of this grant is to support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB) and Office of AIDS Research (OAR).

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Application Due: October 16, 2019

This grant encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease.

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Application Due: October 5, 2019

The purpose of this grant is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription and other substances) and related disorders, prevention of substance use and HIV, and health service utilization.

Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)

Application Due: November 13, 2019

The purpose of this grant is to provide support for a mentored postdoctoral research experience at a research-intensive institution combined with an opportunity to develop critical teaching and mentoring skills at a teaching-intensive partner institution with a diverse student population.

Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)

Letter of Intent Due: October 6, 2019

Application Due: November 6, 2019

The purpose of this grant is to provide support and accelerate human epigenomic investigations focused on identifying and characterizing the mechanisms by which social experiences at various stages in life, both positive and negative, affect gene function and thereby influence health trajectories or modify disease risk in racial/ethnic minority and other health disparity populations.

Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)

Letter of Intent Due: November 4, 2019

Application Due: December 4, 2019

The purpose of this grant is to stimulate the development of new and innovative sustained/extended release drug delivery systems that can achieve extended durations and provide systemic protection from all routes of HIV infection/transmission in at-risk individuals.

Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)

Letter of Intent Due: September 28, 2019

Application Due: October 28, 2019

The purpose of this grant is to develop interventions for physician compliance with recommended prevention guidelines for older adults from the Centers for Disease Control and Prevention (CDC) and the US Preventive Services Task Force (USPTF) and to allow researchers to use data analytics tools, including machine learning approaches, to establish the feasibility of identifying groups of patients not receiving recommended preventive care, and then create scalable, tailored interventions for these groups to help overcome barriers to uptake.

Health Resources and Services Administration

State and Regional Primary Care Association (PCA) Cooperative Agreements

Application Due: November 8, 2019

The purpose of this grant is to provide training and technical assistance (T/TA) to existing and potential Health Center Program award recipients and look-alikes and to provide T/TA to support health centers to provide comprehensive, high quality primary health care and improve the health of individuals and communities, through the following goals: Increase access to comprehensive primary care; Accelerate value-based care delivery; Foster a workforce to address current and emerging needs; Enhance emergency preparedness and response; and Advance clinical quality and performance.

State Offices of Rural Health Coordination and Development Program (SORHCDP)

Application Due: December 20, 2019

The purpose of this grant is to develop and maintain activities that will build the capacity of the 50 State Offices of Rural Health (SORH) and rural stakeholders nationwide through strengthening leadership, increasing opportunities for collaboration, offering education on policy and emerging health issues, and supporting the core functions of the SORH.

August 19 – August 30  

National Institutes of Health

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)

Application Due: October 16, 2019

The purpose of this grant is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)

Application Due: October 16, 2019

The purpose of grant is is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.

NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

Letter of Intent: October 5, 2019

Application Due: November 6, 2019

The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

Application Due: October 9, 2019

The purpose of the grant is to support meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels.

Health Resources and Services Administration

National Rural Health Information Clearinghouse Program

Application Due: December 2, 2019

This notice announces the opportunity to apply for funding under the National Rural Health Information Clearinghouse Program. The purpose of this program is to serve as a national clearinghouse for information on rural health to support access to healthcare and improve population health in rural communities. A successful program will continue to build upon the federally funded resources that currently exist and serve as a primary resource for information, opportunities, and tools related to rural health.

Service Area Competition

Application Due: October 21, 2019

The Health Center Program supports public and private nonprofit community-based and patient-directed organizations that provide primary health care services to the Nation’s medically underserved populations. The purpose of the SAC NOFO is to ensure continued access to affordable, quality primary health care services for communities and populations currently served by the Health Center Program.

Delta States Rural Development Network Grant Program

Application Due: December 6, 2019

Application for funding for the Delta Program, which supports and encourages the development of integrated health care networks to address unmet local health care needs and prevalent health disparities in rural Delta communities. The purpose of the Delta Program is to support organizations located in the eight Delta States (Alabama, Arkansas, Illinois, Kentucky, Louisiana, Mississippi, Missouri, and Tennessee) to promote the planning, implementation, and development of health care networks

August 5 – August 16  

National Institutes of Health

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Letter of Intent: September 10, 2019

Application Due: October 11, 2019

This grant supports applications to develop and implement investigator-initiated clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Clinical trials supported by this FOA include Phase II and above clinical trials. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies.

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Letter of Intent: September 10, 2019

Application Due: October 11, 2019

This grant supports applications to develop and implement a Clinical Coordinating Center for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials for which this funding applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial.

Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional)

Letter of Intent: September 7, 2019

Application Due: October 7, 2019

The purpose of this funding opportunity is to identify abnormalities in circadian-ordered gene expression to improve our understanding of disease phenotypes, etiology, risk stratification, resilience, and therapeutic management in diseases.

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Letter of Intent: October 8, 2019

Application Due: October 9, 2019

This grant opportunity encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Letter of Intent: September 8, 2019

Application Due: October 9, 2019

This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.

Research Education: Short Courses on Alzheimer's Disease and Related Dementias for the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)

Letter of Intent: December 21, 2019

Application Due: January 21, 2020

The goal of this grant is to support short courses geared to behavioral and social scientists who have existing expertise in aging research and can make research contributions in Alzheimer’s disease and Alzheimer's disease-related dementias (AD/ADRD) with additional knowledge about the disease and related research resources.

Indian Health Service

Epidemiology Program, Ending the HIV Epidemic in Indian Country, competing supplement 1

Application Due: September 5, 2019

The purpose of this Indian Health Service competitive supplement is to support communities in reducing new HIV infections and relevant co-morbidities, specifically Sexually Transmitted Infections (STI) and Viral Hepatitis C (HCV) infections, improve HIV-, STI- and HCV-related health outcomes, and to reduce HIV-, STI- and HCV-related health disparities among American Indian/Alaska Native (AI/AN) people.

Health Resources and Services Administration

Maternal and Child Health Field-Initiated Innovative Research Studies (FIRST) Program

Application Due: November 12, 2019

The purpose of this grant is to advance the health and well-being of Maternal and Child health (MCH) populations by supporting innovative, applied, and translational intervention research studies on critical issues affecting MCH populations.

Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B

Application Due: October 15, 2019 

The purpose of this grant is to implement effective and innovative strategies, interventions, approaches, and services to reduce new HIV infections in the United States. The overarching goal for this initiative is to reduce new HIV infections in the United States to less than 3,000 per year by 2030.

Rural Health Network Development Program

Application Due: November 25, 2019

The purpose of this program is to support integrated rural health care networks that have combined the functions of the entities participating in the network, including skilled and experienced staff and a high functioning network board, in order to address the health care needs of the targeted rural community. The program encourages innovative solutions to local health care needs identified by local communities and supports rural communities in preparing for changes within the health care environment.